euro-immunology-2017-posters-accepted-abstracts

33 / 50

Page 101
Notes:
conferenceseries.com
Volume 8, Issue 3 (Suppl) J Clin Cell Immunol, an open access journal
ISSN: 2155-9899 Euro Immunology 2017
June 29-July 01, 2017
June 29-July 01, 2017 Madrid, Spain
8th European
Immunology Conference
The humanized antibody h8G12 prevented arthritis through targeting both TNF-α and RANKL in
DBA/1 monoarthritic mice
Wenming Zhao, Huihui Yuan, Weiwei Lou and Xiaonan Du
Capital Medical University, China
Statement of the Problem: The TNF-α and RANKL are the key pathogenic factors in the onset and progression of rheumatoid
arthritis (RA). TNF-α inhibitors have shown good clinical therapeutic effects of relief inflammation and joint swelling, but single
application of TNF-α agents have a relatively weak protection from cartilage and bone destruction. RANKL are largely produced from
inflamed synovium and cause activation of osteoclasts during the bone remodeling cycle, and an anti-RANKL antibody denosumab
possesses a potential to inhibit joint destruction as well as systemic osteoporosis. The purpose of this study is to prepare humanized
bispecific antibody (h8G12) targeting both TNF-α and RANKL and to evaluate its therapeutic effects on arthritis.
Methodology & Theoretical Orientation: The h8G12 was produced from co-transfected Chinese hamster ovary (CHO) cells. The
identification, purification and characterization of h8G12 were detected by SDS-PAGE, Western blot and indirect ELISA. To evaluate
its therapeutic effects, the monoarthritis model mice were prepared though intra-articular injection of rhTNF-α and rhRANKL.
Findings: The confluence rate of co-transfected CHO cells reached 80% at about 48 h after resuscitation. The concentration of h8G12
antibody in supernatant was kept at a steady state at 96 h after cell passaging. HE staining showed that h8G12 significantly inhibited
more than 50% inflammatory cell infiltration in the joint cavity, peripheral soft tissue and bone marrow. Destruction of cartilage in
h8G12-treated mice was significantly lower than that in positive control group. Interestingly, the joint structure and the thickness
of articular cartilage of the mice in treated group had no significant difference with those in normal ones. The h8G12 inhibited the
differentiation of osteoclasts and significantly decreased the number of osteoclast-like cells.
Conclusion & Significance: The h8G12 ameliorated inflammation and bone destruction through targeting TNF-α and RANKL. The
h8G12 may be a good candidate for inflammatory bone diseases.
Biography
Wenming Zhao has focused on researching the therapeutic strategies and mechanisms in rheumatoid arthritis (RA). His major findings are biological therapies
for collagen-induced arthritis (CIA) including OPG recombinant protein, RANKL-TNF homologous vaccine and humanized antibody. He also devotes to discover
the mechanisms of Ahr signal pathway in joint bone destruction. This study investigated the effects of humanized antibodies h8G12 on relief of bone destruction.
Wenming Zhao et al., J Clin Cell Immunol 2017, 8:3(Suppl)
DOI: 10.4172/2155-9899-C1-037